CryoLife (CRY) Tops Q1 EPS by 5c, Reaffirms FY Guidance
CryoLife (NYSE: CRY) reported Q1 EPS of $0.09, $0.05 better than the analyst estimate of $0.04. Revenue for the quarter came in at $45.1 million versus the consensus estimate of $44.61 million.
GUIDANCE:
CryoLife sees Q2 2017 revenue of $46.5-47 million vs. estimate of $47.4 million.
CryoLife sees FY 2017 EPS of $0.40.5-0.43, sees total revenues of $188-192 million.
For earnings history and earnings-related data on CryoLife (CRY) click here.